Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Bolt Biotherapeutics, Inc.

NASDAQ: BOLT · Life Sciences · 8 alerts · CIK 1641281

Share price
$5.80Close, Nov 16
Market cap
$15.1M
Shares outstanding
2.61MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Bolt Biotherapeutics, Inc. filings on SEC EDGAR ↗

4:08 PM ET 8-K
Business Update

Bolt Biotherapeutics Business Update

Bolt Biotherapeutics entered into a second lease amendment for its Redwood City facilities, accelerating the lease expiration date to December 31, 2027, or earlier upon a strategic transaction. The company paid $1.0 million upfront and agreed to a $4.5 million termination payment upon a future corporate transaction, significantly reducing its ongoing rent and operating expense obligations.

Counterparty
HCP LS Redwood City LLC
Term
through Dec 2027

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.